Vnitr Lek 2023, 69(5):282-288 | DOI: 10.36290/vnl.2023.056

Cardiovascular disease and kidney transplantation

Silvie Rajnochová Bloudíčková
Klinika nefrologie - TC IKEM, Praha

Compared to general population, patients with chronic kidney disease (CKD) exhibit high prevalence of cardiovascular disease (CVD) that increases with a stage of CKD. Traditional and non-traditional risk factors associated with CKD contribute to accelerated atherosclerosis leading to CVD. CVD represents the main cause of morbidity and mortality in CKD population. Pretransplant examination is essential to evaluate and optimize the state of cardiovascular system prior transplantation, thus to minimize risks that could have a negative impact on transplant outcome.

Keywords: dialysis, chronic kidney disease, cardiovascular disease, pretransplant evaluation, kidney transplantation.

Accepted: August 24, 2023; Published: September 12, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rajnochová Bloudíčková S. Cardiovascular disease and kidney transplantation. Vnitr Lek. 2023;69(5):282-288. doi: 10.36290/vnl.2023.056.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end stage renal disease patients. Am J Kidney, DiS. 2001; 38:S26-9. Go to original source...
    2. Jankowski J, Floege J, Fliser D, et al. Cardiovascular disease in chronic kidney disease. Circulation. 2021; 143(11):1157-1172. Go to original source...
    3. Dilsizian V, Gewirtz H, Marwick TH, et al. Cardiac imaging for coronary heart disease JACC. 2021; 14(1):669-682. Go to original source...
    4. Matsushita K, Ballew SH, Wang AEM et al. Epidemiology and risk of cardiovascular disease in population with chronic kidney disease. Nat Rev Nephrol. 2022; 18:696-707. Go to original source... Go to PubMed...
    5. Kalantar­‑Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63:793-808. Go to original source... Go to PubMed...
    6. Specific­‑cause mortality in kidney transplant recipients. Available from: www: https://usrds­‑adr.niddk.nih.gov/2022/
    7. Law JP, Pickup L, Pavlovic D, et al. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment consideration. J Hum Hypertens. 2023; 37(1):1-19. Go to original source... Go to PubMed...
    8. Muntner P, He J, Astor BC, et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16(2):529-38. Go to original source... Go to PubMed...
    9. Trespalacios FC, Taylor AJ, Agodoa LY, et al. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney, DiS. 2003;41(6):1267-77. Go to original source...
    10. Nguyen TC, Babaliaros VC, Razavi SA, et al. Impact of varying degrees of renal dysfunctionon transcatheter and surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2013;146(6):1399-406. Go to original source...
    11. Himbert D, Bouleti C, Iung B, et al. Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. J Am Coll Cardiol 2014, 64(23):2557-8. Go to original source...
    12. Viklický O, Janoušek L, Baláž P, et al. Transplantace ledviny v klinické praxi. Grada Publishing 2008. ISBN 978-80-247-2455-3.Další literatura u autorky a na www.casopisvnitrnilekarstvi.cz
    13. Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO on the evaluation and management of candidates for kidney transplantation. Transplantation 2020; 104: 708-714. Go to original source... Go to PubMed...
    14. Lentine K, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126(5):617-63. Go to original source...
    15. Satyan S, Rocher LL. Impact of kidney transplantation on the progression of cardiovascular disease. Adv Chronic Kidney, DiS. 2004;11(3):274-93. Go to original source...
    16. Wali RK, Wang GS, Gottlieb SS, et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end­‑stage renal disease. J Am Coll Cardiol. 2005, 45(7):1051-60. Go to original source...
    17. Vahanian A, Beyersdorf F, Praz F, et al. 2021ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. Go to original source... Go to PubMed...
    18. Collins AJ, Foley RN, Herzog C, et al Excerpts from the US Renal data system 2009 annual data report. Am j Kidney, DiS. 2010, 55(1 Suppl 1): S1-420, A 426-7. Go to original source...
    19. Hillis LD, Smith PK, Anderson JF, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Thorac Cadiovasc Surg. 2012, 143(1):4-34. Go to original source...
    20. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014, 35(37): 2541-619. Go to original source...
    21. Shroff GR a Herzog CA. Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations. J Am Soc Nephrol. 2016, 27:3521-3529. Go to original source... Go to PubMed...
    22. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013, 34(38):2949-3003, Go to original source...
    23. Valgimigli M, Patialiakas, Thury A, et al. Zotarolimus­‑eluting versus bare­‑metal stents in uncertain drug­‑eluting stent candidates J Am Coll cardiol. 2015, 65(8):805-15. Go to original source... Go to PubMed...
    24. Hoosain J, Hamad E. Adverse Effects of Immunosuppression: Nephrotoxicity, Hypertension, and Metabolic Disease. Handb Exp Pharmacol. 2022;272:337-348. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.